Vimentin and laminin are altered on cheek pouch microvessels of streptozotocin-induced diabetic hamsters

Clinics

Volumn 66, Issue 11, 2011, Pages 1961-1968

  Silva, Jemima Fuentes R ^a   Cyrino, Fatima Z G A ^a   Breitenbach, Marisa M D ^a   Bouskela, Eliete ^a   Carvalho, Jorge José ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cytoskeleton; Diabetes mellitus; Extracellular matrix; Immunohistochemistry; Microcirculation

Indexed keywords

ACETYLCHOLINE; HISTAMINE; LAMININ; VASODILATOR AGENT; VIMENTIN;

ANIMAL; ARTERIOLE; ARTICLE; CELL MEMBRANE PERMEABILITY; CHEEK; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HAMSTER; MALE; METABOLISM; MICROVASCULATURE; PATHOLOGY; RANDOMIZATION; SYRIAN HAMSTER; TIME; ULTRASTRUCTURE; VASCULARIZATION;

ACETYLCHOLINE; ANIMALS; ARTERIOLES; CELL MEMBRANE PERMEABILITY; CHEEK; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HISTAMINE; LAMININ; MALE; MESOCRICETUS; MICROVESSELS; RANDOM ALLOCATION; TIME FACTORS; VASODILATOR AGENTS; VIMENTIN;

EID: 81555211939     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011001100018     Document Type: Article

References (35)

1. Aguiar LG, Villela NR, Bouskela E. [Microcirculation in diabetes: implications for chronic complications and treatment of the disease]. Arq Bras Endocrinol Metabol. 2007;51:204-11.
2. Duling BR, Damon DH. An examination of the measurement of flow heterogeneity in striated muscle. Circ Res. 1987;60:1-13.
3. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109:143-59.
4. Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL, Smit A. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol. 2008;7:29.
5. Joyner WL, Mayhan WG, Johnson RL, Phares CK. Microvascular alterations develop in Syrian hamsters after the induction of diabetes mellitus by streptozotocin. Diabetes. 1981;30:93-100.
6. Svensjo E, Cyrino F, Michoud E, Ruggiero D, Bouskela E, Wiernsperger N. Vascular permeability increase as induced by histamine or bradykinin is enhanced by advanced glycation endproducts (AGEs). J Diabetes Complications. 1999;13:187-90.
7. Sotnikova R, Skalska S, Okruhlicova L, Navarova J, Kyselova Z, Zurova J, et al. Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes. Gen Physiol Biophys. 2006;25:289-302.
8. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med. 2009;6:16-26.
9. Mott RE, Helmke BP. Mapping the dynamics of shear stress-induced structural changes in endothelial cells. Am J Physiol Cell Physiol. 2007;293:C1616-26.
10. Moncada S. Adventures in vascular biology: a tale of two mediators. Philos Trans R Soc Lond B Biol Sci. 2006;361:735-59.
11. Zhang H, Sunnarborg SW, McNaughton KK, Johns TG, Lee DC, Faber JE. Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodeling. Circ Res. 2008;102:1275-85.
12. Jarvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109:1750-5.
13. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129-46.
14. Liu Y, Li H, Bubolz AH, Zhang DX, Gutterman DD. Endothelial cytoskeletal elements are critical for flow-mediated dilation in human coronary arterioles. Med Biol Eng Comput. 2008;46:469-78.
15. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. An Acad Bras Cienc. 2003;75:469-86.
16. Mendonca Lde S, Fernandes-Santos C, Mandarim-de-Lacerda CA. Cardiac and aortic structural alterations due to surgically-induced menopause associated with renovascular hypertension in rats. Int J Exp Pathol. 2007;88:301-9.
17. Bonnet F, Cao Z, Cooper ME, Cox AJ, Kelly DJ, Gilbert RE. Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes. Diabetes Metab. 2003;29:386-92.
18. Matsumoto T, Oda SI, Kobayashi T, Kamata K. Flow-induced endothelium- dependent vasoreactivity in rat mesenteric arterial bed. J Smooth Muscle Res. 2004;40:1-14.
19. Pieper GM. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia. 1999;42:204-13.
20. Llorach MA, Bohm GM, Leme JG. Decreased vascular reactions to permeability factors in experimental diabetes. Br J Exp Pathol. 1976;57:747-54.
21. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, et al. Effects of high glucose and TGF-beta1 on the expressionof collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int. 2002;62:901-13.
22. Kobayashi T, Kaneda A, Kamata K. Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta. Br J Pharmacol. 2003;140:285-94.
23. Harrington MA, Daub R, Song A, Stasek J, Garcia JG. Interleukin 1 alpha mediated inhibition of myogenic terminal differentiation: increased sensitivity of Ha-ras transformed cultures. Cell Growth Differ. 1992;3:241-8.
24. Weber E, Rossi A, Solito R, Sacchi G, Agliano M, Gerli R. Focal adhesion molecules expression and fibrillin deposition by lymphatic and blood vessel endothelial cells in culture. Microvasc Res. 2002;64:47-55.
25. Wegener KL, Partridge AW, Han J, Pickford AR, Liddington RC, Ginsberg MH, et al. Structural basis of integrin activation by talin. Cell. 2007;128:171-82.
26. Lee TY, Gotlieb AI. Early stages of endothelial wound repair: conversion of quiescent to migrating endothelial cells involves tyrosine phosphorylation and actin microfilament reorganization. Cell Tissue Res. 1999;297:435-50.
27. Pekiner C, Cullum NA, Hughes JN, Hargreaves AJ, Mahon J, Casson IF, et al. Glycation of brain actin in experimental diabetes. J Neurochem. 1993;61:436-42.
28. Loufrani L, Henrion D. Role of the cytoskeleton in flow (shear stress)- induced dilation and remodeling in resistance arteries. Med Biol Eng Comput. 2008;46:451-60.
29. Lee SE, Kamm RD, Mofrad MR. Force-induced activation of talin and its possible role in focal adhesion mechanotransduction. J Biomech. 2007;40:2096-106.
30. Sasaki T, Fassler R, Hohenester E. Laminin: the crux of basement membrane assembly. J Cell Biol. 2004;164:959-63.
31. Helmke BP. Molecular control of cytoskeletal mechanics by hemodynamic forces. Physiology (Bethesda). 2005;20:43-53.
32. Schopferer M, Bar H, Hochstein B, Sharma S, Mucke N, Herrmann H, et al. Desmin and vimentin intermediate filament networks: their viscoelastic properties investigated by mechanical rheometry. J Mol Biol. 2009;388:133-43.
33. Skalli O, Bloom WS, Ropraz P, Azzarone B, Gabbiani G. Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. J Submicrosc Cytol. 1986;18:481-93.
34. Gonzales M, Weksler B, Tsuruta D, Goldman RD, Yoon KJ, Hopkinson SB, et al. Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol Biol Cell. 2001;12:85-100.
35. Tomasek JJ, Haaksma CJ, Schwartz RJ, Vuong DT, Zhang SX, Ash JD, et al. Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci. 2006;47:2693-700.